Firas Hamdan
Impact in
-
- Immunotherapy and Immune Responses
-
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 14
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 3
- Oncology 11
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Vincenzo Cerullo (16 shared papers)Beatriz Martins (9 shared papers)Mikaela Grönholm (8 shared papers)Manlio Fusciello (13 shared papers)Jacopo Chiaro (11 shared papers)Sara Feola (11 shared papers)Erkko Ylösmäki (9 shared papers)Cristian Capasso (3 shared papers)
- Journals
- Molecular Therapy — Oncolytics (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Cancer Research (2 papers)Human Gene Therapy (1 paper)Nature Communications (1 paper)
- Partner nations
- FinlandItalyNetherlands
In The Last Decade
Firas Hamdan
20 papers receiving 447 citations
Peers
Comparison fields: 5 of 74
- Immunology 171
- Oncology 216
- Biotechnology 52
- Genetics 93
- Molecular Biology 160
Countries citing papers authored by Firas Hamdan
This map shows the geographic impact of Firas Hamdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Firas Hamdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Firas Hamdan more than expected).
Fields of papers citing papers by Firas Hamdan
This network shows the impact of papers produced by Firas Hamdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Firas Hamdan. The network helps show where Firas Hamdan may publish in the future.
Co-authors
The 25 scholars most cited alongside Firas Hamdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 97 | |
| 2 | 2021 | 91 | |
| 3 | 2020 | 40 | |
| 4 | 2019 | 29 | |
| 5 | 1996 | 29 | |
| 6 | 2022 | 26 | |
| 7 | 2021 | 25 | |
| 8 | 2021 | 22 | |
| 9 | 2023 | 22 | |
| 10 | 2020 | 17 | |
| 11 | 2022 | 14 | |
| 12 | 2024 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2022 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About Firas Hamdan
Firas Hamdan is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Dermatology, having authored 20 papers that have together received 453 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (10 papers), Virus-based gene therapy research (7 papers), vaccines and immunoinformatics approaches (3 papers), Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA Interference and Gene Delivery (2 papers) and Facial Rejuvenation and Surgery Techniques (2 papers). The work is most often cited by research in Immunology (171 citations), Oncology (216 citations), Biotechnology (52 citations), Genetics (93 citations) and Molecular Biology (160 citations). Firas Hamdan has collaborated with scholars based in Finland, Italy and Netherlands. Frequent co-authors include Vincenzo Cerullo, Beatriz Martins, Mikaela Grönholm, Manlio Fusciello, Jacopo Chiaro, Sara Feola, Erkko Ylösmäki, Cristian Capasso, Karita Peltonen and Siri Tähtinen. Their work appears in journals such as Molecular Therapy — Oncolytics, Journal for ImmunoTherapy of Cancer, Cancer Research, Human Gene Therapy and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.